MentionFox
Home › funding signals › Iambic Therapeutics, Inc. › competitors
Competitors and similar companies

Iambic Therapeutics, Inc.'s competitors and similar companies

The 5 nearest raises on the records held here, in the same industry group (Biotechnology), side by side with Iambic Therapeutics, Inc..

Back to the full Iambic Therapeutics, Inc. record.

Compare these too: Superluminal Medicines, Inc. · Airway Therapeutics, Inc. · Gossamer Bio, Inc. · Cloverleaf Bio, Inc. · Episteme Prognostics, Inc.

← The full Iambic Therapeutics, Inc. record · every deck on file · all funding signals

100% percentile
$65.97M
of raises in its group are smaller

Against the 9 raises on file in Biotechnology. Median $14.80M, largest $65.97M.

Offering size, this raise against its peers
Bigger than 5 of the 5 comparable raises here · largest of the set
Iambic Therapeutics, Inc.
$65.97M
Superluminal Medicines, Inc.
$65.48M
Airway Therapeutics, Inc.
$43.50M
Gossamer Bio, Inc.
$25M
Cloverleaf Bio, Inc.
$14.80M
Episteme Prognostics, Inc.
$5.09M

Bars are to scale against $65.97M, the largest of the six. The dotted line is the median of all 9 raises on file in Biotechnology. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.

How does your raise compare?

Enter an amount to place it against the filings on record.

Percentiles are drawn from the 906 Form D filings held here that state an amount, filed between 3 and 9 September 2026 — 876 of them in the 17 industry groups large enough to rank against (5 filings minimum).

RankCompanyScore Raise sizeFiledPeople namedInvestors inForm D cadenceFiling history
1Iambic Therapeutics, Inc.this pageleads97$65.97M · 100th pctadds 392026-09-09 · 2d agoadds 2313adds 2316adds 12not statednot stated
2Gossamer Bio, Inc.86$25M · 63rd pctadds 252026-09-04 · 7d agoadds 2311adds 2338adds 156not scored467 since 2018not scored
3Superluminal Medicines, Inc.82$65.48M · 88th pctadds 342026-09-03 · 8d agoadds 235adds 1316adds 124not scored4 since 2023not scored
4Airway Therapeutics, Inc.80$43.50M · 75th pctadds 292026-09-09 · 2d agoadds 235adds 12116adds 16not statednot stated
5Cloverleaf Bio, Inc.68$14.80M · 50th pctadds 202026-09-09 · 2d agoadds 235adds 1312adds 12not statednot stated
6Episteme Prognostics, Inc.57$5.09M · 25th pctadds 92026-09-04 · 7d agoadds 233adds 1314adds 126not scored6 since 2022not scored

A score out of 100 comparing what each company's record shows for raise size within its industry group, filing recency, people named on the filing and investors disclosed.

  • Raise size within its industry groupup to 39
  • Filing recencyup to 23
  • People named on the filingup to 23
  • Investors disclosedup to 15
  • Form D cadence and filing history depthshown, not scored
  • 75 and up
  • 55 to 74
  • 35 to 54
  • under 35
Company On the record Industry group Filed
Superluminal Medicines, Inc.$65.48MBiotechnology2026-09-03
Airway Therapeutics, Inc.$43.50MBiotechnology2026-09-09
Gossamer Bio, Inc.$25MBiotechnology2026-09-04
Cloverleaf Bio, Inc.$14.80MBiotechnology2026-09-09
Episteme Prognostics, Inc.$5.09MBiotechnology2026-09-04
Iambic Therapeutics, Inc. (this page)$65.97MBiotechnology2026-09-09

8 other records here are in this industry group.

How this list is chosen

Nearest by stated offering size, inside the industry group the filing itself declares (Biotechnology). Nothing is inferred about what a company does.